Mitochondrial biogenesis: a potential therapeutic target for osteoarthritis
- PMID: 32417558
- DOI: 10.1016/j.joca.2020.03.018
Mitochondrial biogenesis: a potential therapeutic target for osteoarthritis
Abstract
Mitochondrial dysfunction of human articular chondrocytes is considered a hallmark of cartilage degradation and OA pathogenesis. Due to the huge number of cellular processes in which mitochondria is implicated, even in the closed context of cellular respiration, the term mitochondrial function can refer to a variety of features which include fusion and fission, turnover (biogenesis and mitophagy), and plasticity. Mitochondrial biogenesis and mainly mitochondrial fusion and reduced mitophagy, contribute to the metabolic disorder and inflammation that occurs during OA. Reduced MFN2 and increased PARKIN expression represent potential therapeutic targets for the treatment of joint cartilage degradation during the OA process.
Keywords: Mfn2; Mitochondrial dynamics; Osteoarthritis.
Copyright © 2020 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Comment on
-
MFN2 contributes to metabolic disorders and inflammation in the aging of rat chondrocytes and osteoarthritis.Osteoarthritis Cartilage. 2020 Aug;28(8):1079-1091. doi: 10.1016/j.joca.2019.11.011. Epub 2020 May 19. Osteoarthritis Cartilage. 2020. PMID: 32416221
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
